Pharma Cos., FDA Debate 'Same Drug' In Orphan Drug Case
IP Law 360
MAY 10, 2024
Food and Drug Administration faced off in D.C. federal court Friday over allegations that the federal agency wrongly approved a treatment that rivals Jazz Pharma's narcolepsy drug despite Jazz's exclusivity rights under the Orphan Drug Act. Two pharmaceutical companies and the U.S.
Let's personalize your content